Psoriasis

The FDA approved drugs and products for many dermatological diseases and conditions in 2020. Here are some of the top-read articles on Healio regarding this year’s dermatology FDA approvals.

The rate of psoriasis flares did not increase during or immediately after systemic corticosteroid treatment, according to a study published in JAMA Dermatology.

Roflumilast foam showed statistically significant improvements in the treatment of scalp and body psoriasis in a phase 2 trial, Arcutis announced in a press release.

Greater use of effective psoriasis therapies can affect patient-reported outcomes and improve treatment satisfaction, according to a presenter at the European Academy of Dermatology and Venereology virtual congress.

Smartphone photos taken at home by patients with psoriasis can be reliably used to assess severity of disease, according to a poster presented at the European Academy of Dermatology and Venereology virtual congress.

Joint care by a dermatologist, rheumatologist and other specialists can mitigate the “accelerated trajectory of comorbidities” that can often happen in patients with psoriatic disease, according to a presenter at ACR 2020.

Risankizumab was associated with significant improvement over ustekinumab and placebo in a number of quality-of-life parameters in a cohort of patients with psoriasis, according to a study.

Among patients with psoriatic arthritis, daily upadacitinib doses of either 15 or 30 mg improved musculoskeletal symptoms, psoriasis, physical function, pain, fatigue and radiographic progression, according to a speaker at ACR Convergence.

The use of social media continues to grow exponentially, and for many people with psoriasis, platforms such as Twitter and Instagram have become places where they can find information and acceptance.

A drug comprised of a nonliving single strain commensal microbe showed signs of safe and effective treatment of mild to moderate psoriasis, according to a presentation at the European Academy of Dermatology and Venereology virtual congress.